Description
Tirzepatide is a synthetic dual GIP/GLP-1 receptor agonist widely referenced in metabolic and endocrine research literature, studied for its effects on glucose regulation, insulin sensitivity, and body weight in animal and clinical research models. This vial (10mg) is manufactured in the USA under controlled laboratory conditions and is intended strictly for laboratory research use. It is not a drug, dietary supplement, or cosmetic, and is not intended for human or animal consumption, diagnostic, or therapeutic use. Product handling should be restricted to qualified professionals in a controlled research setting.






Reviews
There are no reviews yet.